Since SCCA-1 overexpression has been associated to a worst prognosis and chemoresistance in several different tumor types [8, 14–16, 24], we assessed SCCA expression in a series of BAc specimens selected according to their post-neoadjuvant chemotherapy Mandard status (Figure 3A). This evidence concerns the gene SERPINB4 and neoplasm.